INAHTAInternational Network of HTA Agencies, HTA Agency Network
The International Network of Agencies for Health Technology Assessment, connecting national and regional agencies worldwide for information sharing.
HTA & Reimbursement
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
- Topic: HTA & Reimbursement
- 43 terms
- Editor reviewed
IQWiGInstitute for Quality and Efficiency in Health Care, German HTA Institute
The Institute for Quality and Efficiency in Health Care, Germany's body conducting evidence-based benefit assessments informing G-BA coverage decisions.
Joint AssessmentCollaborative Assessment, Joint Clinical Assessment
An assessment conducted collaboratively by multiple countries or bodies to reduce duplication and promote consistency across jurisdictions.
Managed Access AgreementMAA, NICE Managed Access
A formal arrangement between manufacturer and payer establishing conditions, such as price or eligibility criteria, under which a new treatment is made available.
Manufacturer SubmissionCompany Submission, Sponsor Dossier
The complete package of clinical and economic evidence a manufacturer provides in support of a coverage or reimbursement application.
Multi-Criteria Decision AnalysisMCDA, Multi-Criteria Appraisal, Multi-Criteria Analysis HTA
Multi-criteria decision analysis is a family of structured methods that compares alternatives across multiple explicit criteria and incorporates judgments about the trade-offs among them.
Multiple Technology AssessmentMTA, Multi-Technology Appraisal
An assessment process evaluating several related technologies for the same condition together within a single, coordinated review.
Negative RecommendationDo-Not-Reimburse Recommendation, Rejection
A body's formal decision not to recommend a technology for funding, based on unacceptable cost-effectiveness at the reviewed price.